Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-22-000816

Chief Scientific Officer acquired 42,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Kidron Miriam Chief Scientific Officer 2022-01-03 Grant or award +42,000 183,666 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Kidron Miriam Chief Scientific Officer 2022-01-03 Grant or award · Stock Option (right to buy) +72,000 72,000 D: show line 2 in the form
Loading xslF345X03/ownership.xml…